610 related articles for article (PubMed ID: 21859291)
21. Correlates of the MMPI-2-RF in a college setting.
Forbey JD; Lee TT; Handel RW
Psychol Assess; 2010 Dec; 22(4):737-44. PubMed ID: 20804257
[TBL] [Abstract][Full Text] [Related]
22. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
Sellbom M; Wygant D; Bagby M
Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
[TBL] [Abstract][Full Text] [Related]
23. Differential sensitivity of the Response Bias Scale (RBS) and MMPI-2 validity scales to memory complaints.
Gervais RO; Ben-Porath YS; Wygant DB; Green P
Clin Neuropsychol; 2008 Dec; 22(6):1061-79. PubMed ID: 18609315
[TBL] [Abstract][Full Text] [Related]
24. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
Gass CS; Odland AP
J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of MMPI-2-RF Symptom Validity Scales and Performance Validity Test Relationships in a Diverse Mixed Neuropsychiatric Setting.
De Boer AB; Phillips MS; Barwegen KC; Obolsky MA; Rauch AA; Pesanti SD; Tse PKY; Ovsiew GP; Jennette KJ; Resch ZJ; Soble JR
Psychol Inj Law; 2023; 16(1):61-72. PubMed ID: 36348958
[TBL] [Abstract][Full Text] [Related]
26. Examination of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) validity and substantive scales in patients with electrical injury.
Soble JR; Resch ZJ; Schulze ET; Paxton JL; Cation B; Friedhoff C; Costin C; Fink JW; Lee RC; Pliskin NH
Clin Neuropsychol; 2019 Nov; 33(8):1501-1515. PubMed ID: 31106672
[No Abstract] [Full Text] [Related]
27. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
[TBL] [Abstract][Full Text] [Related]
28. Critiquing symptom validity tests for posttraumatic stress disorder: a modification of Hartman's criteria.
Morel KR; Marshman KC
J Anxiety Disord; 2008 Dec; 22(8):1542-50. PubMed ID: 18423958
[TBL] [Abstract][Full Text] [Related]
29. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
Tolin DF; Steenkamp MM; Marx BP; Litz BT
Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing between neuropsychological malingering and exaggerated psychiatric symptoms in a neuropsychological setting.
Ruocco AC; Swirsky-Sacchetti T; Chute DL; Mandel S; Platek SM; Zillmer EA
Clin Neuropsychol; 2008 May; 22(3):547-64. PubMed ID: 17853126
[TBL] [Abstract][Full Text] [Related]
31. Examination of the new MMPI-2 Response Bias Scale (Gervais): relationship with MMPI-2 validity scales.
Nelson NW; Sweet JJ; Heilbronner RL
J Clin Exp Neuropsychol; 2007 Jan; 29(1):67-72. PubMed ID: 17162723
[TBL] [Abstract][Full Text] [Related]
32. Neurobehavioral symptom validity in U.S. Department of Veterans Affairs (VA) mild traumatic brain injury evaluations.
Ashendorf L
J Clin Exp Neuropsychol; 2019 May; 41(4):432-441. PubMed ID: 30712457
[TBL] [Abstract][Full Text] [Related]
33. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
Tsushima WT; Geling O; Fabrigas J
Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
[TBL] [Abstract][Full Text] [Related]
34. Validation of the MMPI-2 Response Bias Scale and Henry-Heilbronner Index in a U.S. veteran population.
Young JC; Kearns LA; Roper BL
Arch Clin Neuropsychol; 2011 Apr; 26(3):194-204. PubMed ID: 21459900
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of the Neurobehavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury.
Lange RT; Brickell TA; Lippa SM; French LM
J Clin Exp Neuropsychol; 2015; 37(8):853-62. PubMed ID: 26245293
[TBL] [Abstract][Full Text] [Related]
36. Further development and construct validation of MMPI-2-RF indices of global psychopathy, fearless-dominance, and impulsive-antisociality in a sample of incarcerated women.
Phillips TR; Sellbom M; Ben-Porath YS; Patrick CJ
Law Hum Behav; 2014 Feb; 38(1):34-46. PubMed ID: 23855322
[TBL] [Abstract][Full Text] [Related]
37. An examination of the association between psychopathy and dissimulation using the MMPI-2-RF validity scales.
Marion BE; Sellbom M; Salekin RT; Toomey JA; Kucharski LT; Duncan S
Law Hum Behav; 2013 Aug; 37(4):219-30. PubMed ID: 22799603
[TBL] [Abstract][Full Text] [Related]
38. Clusters of financially incentivized chronic pain patients using the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF).
Aguerrevere LE; Calamia MR; Greve KW; Bianchini KJ; Curtis KL; Ramirez V
Psychol Assess; 2018 May; 30(5):634-644. PubMed ID: 28627924
[TBL] [Abstract][Full Text] [Related]
39. An Introduction to the Minnesota Multiphasic Personality Inventory-Adolescent-Restructured Form (MMPI-A-RF).
Handel RW
J Clin Psychol Med Settings; 2016 Dec; 23(4):361-373. PubMed ID: 27752979
[TBL] [Abstract][Full Text] [Related]
40. Comparability of scores on the MMPI-2-RF scales generated with the MMPI-2 and MMPI-2-RF booklets.
Van der Heijden PT; Egger JI; Derksen JJ
J Pers Assess; 2010 May; 92(3):254-9. PubMed ID: 20408025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
